Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 14 6.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 14 6.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM CHLORIDE 14.6%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Sodium chloride 14.6% is a hypertonic saline solution that increases serum osmolality, drawing water from the intracellular space into the extracellular compartment, thereby reducing cerebral edema and intracranial pressure. It also acts as a volume expander and electrolyte replenisher.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion via central line; typical dose for severe hyponatremia is 100-150 mL over 20 minutes (150 mL max) for acute correction, then 0.5-1 mmol/L/hour increase not exceeding 8 mmol/L in 24 hours.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable; sodium and chloride ions are homeostatically regulated with no defined terminal half-life. Rapidly redistributed and excreted, with clinical effect related to plasma concentration.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% as unchanged sodium and chloride ions; minor fecal (<5%) and negligible biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte